原发性肝细胞癌经导管肝动脉化疗性栓塞治疗技术操作规范专家共识

[11] Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma [J]. SEMINARS IN LIVER DISEASE, 2010, 30 (01) : 52 - 60

[12] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J] . Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Lancet Oncology . 2009 (1)

[13] Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma: Prognostic and Therapeutic Implications[J] . Nazario Portolani,Arianna Coniglio,Sara Ghidoni,Mara Giovanelli,Anna Benetti,Guido Alberto Massimo Tiberio,Stefano Maria Giulini.Annals of Surgery . 2006 (2)

[14] Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (07) : 955 - 961

[15] Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey [J]. CANCER, 2004, 101 (04) : 796 - 802

[16] Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (11) : 1209 - 1216

[17] Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J] . Josep M. Llovet,Jordi Bruix.Hepatology . 2003 (2)

[18] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J] . The Lancet . 2002 (9319)

[19] 125I粒子植入联合肝动脉栓塞化疗治疗肝癌. 宋进华,顾建平,楼胜文,等. 中华放射学杂志 . 2008

[20] Effective hepatic artery chemo-embolization for advanced hepatocellular carcinoma with extensive tumor thrombus through the hepatic vein. Kashima Y,Miyazaki M,Ito H,et al. Journal of Gastroenterology . 1999

[11] Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma [J]. SEMINARS IN LIVER DISEASE, 2010, 30 (01) : 52 - 60

[12] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial[J] . Ann-Lii Cheng,Yoon-Koo Kang,Zhendong Chen,Chao-Jung Tsao,Shukui Qin,Jun Suk Kim,Rongcheng Luo,Jifeng Feng,Shenglong Ye,Tsai-Sheng Yang,Jianming Xu,Yan Sun,Houjie Liang,Jiwei Liu,Jiejun Wang,Won Young Tak,Hongming Pan,Karin Burock,Jessie Zou,Dimitris Voliotis,Zhongzhen Guan.Lancet Oncology . 2009 (1)

[13] Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma: Prognostic and Therapeutic Implications[J] . Nazario Portolani,Arianna Coniglio,Sara Ghidoni,Mara Giovanelli,Anna Benetti,Guido Alberto Massimo Tiberio,Stefano Maria Giulini.Annals of Surgery . 2006 (2)

[14] Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005, 16 (07) : 955 - 961

[15] Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey [J]. CANCER, 2004, 101 (04) : 796 - 802

[16] Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (11) : 1209 - 1216

[17] Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival[J] . Josep M. Llovet,Jordi Bruix.Hepatology . 2003 (2)

[18] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J] . The Lancet . 2002 (9319)

[19] 125I粒子植入联合肝动脉栓塞化疗治疗肝癌. 宋进华,顾建平,楼胜文,等. 中华放射学杂志 . 2008

[20] Effective hepatic artery chemo-embolization for advanced hepatocellular carcinoma with extensive tumor thrombus through the hepatic vein. Kashima Y,Miyazaki M,Ito H,et al. Journal of Gastroenterology . 1999